Simplex Trading, LLC Athenex, Inc. Transaction History

Simplex Trading, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	SELL	$0.12 - $0.21 $585 - $1,025	-4,881 Reduced 99.19%	40 $0
Q3 2022 Nov 04, 2022	SELL	$0.24 - $1.11 $806 - $3,731	-3,362 Reduced 40.59%	4,921 $1,000
Q2 2022 Aug 03, 2022	BUY	$0.41 - $0.91 $3,396 - $7,537	8,283 New	8,283 $3,000
Q1 2022 May 02, 2022	SELL	$0.79 - $1.59 $75,045 - $151,040	-94,994 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$1.36 - $2.94 $128,246 - $277,239	94,299 Added 13568.2%	94,994 $129,000
Q2 2021 Aug 12, 2021	SELL	$3.71 - $5.13 $224,595 - $310,559	-60,538 Reduced 98.86%	695 $3,000
Q1 2021 Apr 26, 2021	BUY	$4.08 - $14.75 $199,964 - $722,912	49,011 Added 401.01%	61,233 $263,000
Q4 2020 Feb 02, 2021	BUY	$11.06 - $14.01 $135,175 - $171,230	12,222 New	12,222 $135,000
Q1 2020 Apr 29, 2020	SELL	$5.71 - $15.85 $126,013 - $349,793	-22,069 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$9.6 - $17.75 $211,862 - $391,724	22,069 New	22,069 $336,000
Q4 2018 Jan 16, 2019	SELL	$10.24 - $15.49 $6,144 - $9,294	-600 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$15.53 - $19.97 $9,318 - $11,982	600 New	600 $9,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.